Market Cap 366.61M
Revenue (ttm) 10.00M
Net Income (ttm) -130.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,306.40%
Debt to Equity Ratio 1.26
Volume 1,804,800
Avg Vol 885,082
Day's Range N/A - N/A
Shares Out 51.49M
Stochastic %K 82%
Beta 0.57
Analysts Strong Sell
Price Target $13.00

Latest News on VSTM

Verastem Oncology Announces $75 million Private Placement

Apr 25, 2025, 9:00 AM EDT - 21 hours ago

Verastem Oncology Announces $75 million Private Placement


Verastem: Planning The PDUFA Run-Up

Jan 3, 2025, 11:56 AM EST - 4 months ago

Verastem: Planning The PDUFA Run-Up


Verastem: BLA Acceptance Puts Key Goals In Sight

Jan 2, 2025, 11:39 AM EST - 4 months ago

Verastem: BLA Acceptance Puts Key Goals In Sight


Verastem: Preparing For Upcoming Catalysts

Nov 27, 2024, 1:28 PM EST - 5 months ago

Verastem: Preparing For Upcoming Catalysts


Verastem: Market Overreaction Creates A Dip Buying Opportunity

Jun 10, 2024, 10:51 AM EDT - 11 months ago

Verastem: Market Overreaction Creates A Dip Buying Opportunity


Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)

May 26, 2024, 2:02 AM EDT - 11 months ago

Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)


Verastem opened 70% down on Friday: what happened?

May 24, 2024, 11:30 AM EDT - 1 year ago

Verastem opened 70% down on Friday: what happened?


Harvest ETFs announces May 2024 Distributions

May 24, 2024, 7:30 AM EDT - 1 year ago

Harvest ETFs announces May 2024 Distributions

CLF